Alterity Therapeutics Raises $3.25M AUD in Placement

TL;DR

**Alterity Therapeutics just raised $3.25M AUD in a placement, boosting their cash for drug development.**

AI Summary

Alterity Therapeutics Limited announced on February 23, 2024, that it successfully raised $3.25 million AUD through a placement. This capital raise is intended to support the company's ongoing operations as a development stage enterprise. The filing also indicates that this 6-K report is incorporated by reference into several of its existing Registration Statements on Form S-8 and Form F-3, including files 333-251073 and 333-274816.

Why It Matters

This capital raise provides Alterity Therapeutics with additional funding to advance its drug development programs, which is crucial for a development-stage biotechnology company.

Risk Assessment

Risk Level: medium — As a development-stage enterprise, Alterity Therapeutics relies heavily on capital raises to fund its operations, and future funding is not guaranteed.

Key Numbers

• $3.25M AUD — Capital Raised (Funding for ongoing operations and drug development)

Key Players & Entities

• Alterity Therapeutics Limited (company) — Registrant and company raising capital
• $3.25 million AUD (dollar_amount) — Amount raised in placement
• February 2024 (date) — Month of report
• February 23, 2024 (date) — Conformed period of report and filed as of date
• 333-251073 (company) — Form S-8 Registration Statement file number
• 333-274816 (company) — Form F-3 Registration Statement file number

FAQ

Key Financial Figures

• $3.25 M — : 99.1 Alterity Therapeutics Raises $3.25 M AUD in Placement 1 SIGNATURE Pursu

Filing Documents

• ea0200569-6k_alterity.htm (6-K) — 14KB
• ea0200569ex99-1_alterity.htm (EX-99.1) — 17KB
• ex99-1_001.jpg (GRAPHIC) — 4KB
• 0001213900-24-016246.txt ( ) — 37KB

From the Filing

OF FOREIGN PRIVATE ISSUER SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-163 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Alterity Therapeutics Limited (Name of Registrant) Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073 , 333-248980 and 333-228671 ) and our Registration Statements on Form F-3 (Files No. 333-274816 , 333-251647 , 333-231417 and 333-250076 ) ALTERITY THERAPEUTICS LIMITED (a development stage enterprise) The following exhibits are submitted: 99.1 Alterity Therapeutics Raises $3.25 M AUD in Placement 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alterity Therapeutics Limited By: /s/ Geoffrey P. Kempler Geoffrey P. Kempler Chairman Date: February 23 , 2024 2

View Full Filing

View this 6-K filing on SEC EDGAR